Pas de connexion internet — affichage de la version enregistrée de la page.

Q32 Bio Inc

USUSD
← Vers le Screener
US:QTTBLSE:0T6G

Q32 Bio Inc (US:QTTB) — Biotechnology: Pharmaceutical Preparations. Nombre de places boursières sur lesquelles les actions de la société sont cotées : 2. Sur cette page : cours et graphique, dividendes, principaux actionnaires et historique du nombre d'actions.

À propos de l'entreprise

Site Web
q32bio.com
Secteur
Health Care · Biotechnology: Pharmaceutical Preparations
Siège Social
WALTHAM, United States
PDG
Jodie Pope Morrison
Employés
22
Actions en Circulation
29.77 M au 2026-08-03
Flottant
14.64 M
Capitalisation Boursière
248.28 M USD
Initiés
2.1%
Investisseurs Institutionnels
80.73%
Secteur d'Activité (SIC)
Pharmaceutical Preparations
FCF
−33.5 M USD
Dette
0 USD
trésorerie nette
Résultats et FCF — pour les 12 mois à 30.06.2026 (dernier rapport de l'entreprise).
Description

Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human anti–interleukin-7 receptor alpha antagonist monoclonal antibody which completed Phase 2a clinical trials, designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb – CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition and a range of other indications. The company was founded in 2017 and is based in Waltham, Massachusetts.

Bourses et Tickers

BourseTickerDevisePrixType
US USA StocksQTTB principaleUSD8.09 +1.25%actions ordinaires
LSE London Stock Exchange0T6G IOBUSD8.83 +0.00%actions ordinaires

Cours sur 3 Mois

jour de hausse jour de baisseSurvolez / touchez un jour — cours d'ouverture, de clôture, plus haut et plus bas
publicité

Principaux Actionnaires

DétenteurParticipationActionsDate du Rapport
Orbimed Advisors LLC.13.87%4.13 M2026-06-30
Boxer Capital Management…10.58%3.15 M2026-06-30
Atlas Venture Life Scien…9.13%2.72 M2026-06-30
BVF Inc.7.89%2.35 M2026-06-30
RA Capital Management, L…7.84%2.33 M2026-06-30
Point72 Asset Management…3.94%1.17 M2026-06-30
Opaleye Management Inc.3.13%931 0002026-06-30
Logos Global Management…2.69%800 0002026-06-30
Summittx Capital, L.P.2.46%733 7742026-06-30
Vanguard Capital Managem…1.74%518 8032026-06-30
American Century ETF Tru…1.74%518 2522026-08-31
VANGUARD INDEX FUNDS-Van…1.31%389 1152026-06-30
MORRISON JODIE POPE (Chi…≈1.15%343 2592026-08-25
VIOLETTE SHELIA M (Offic…≈0.55%164 0482026-08-25
KALOWSKI LEE (President)≈0.47%138 4712026-08-25
VANGUARD INDEX FUNDS-Van…0.4%119 2692026-06-30
MANKE ISAAC (Director)≈0.18%53 5212026-06-30
Fidelity Concord Street…0.17%51 0152026-07-31
First TRT Exch-Trd Fd.-F…0.15%45 4112026-08-31
CAMPAGNA JASON (Officer)≈0.13%37 5002025-02-24
Bridgeway Funds, Inc.-Ul…0.12%34 6132026-06-30
iShares Trust-iShares Mi…0.1%29 2712026-08-31
American Century ETF Tru…0.08%22 6222026-08-31
Fidelity Concord Street…0.07%19 7922026-07-31
American Century ETF Tru…0.06%17 8582026-08-31
ORBIMED ADVISORS, L.L.C.…——2026-05-28
XU DIYONG (Director and…——2026-05-28